Live From Shows
-
CPhI North America
Emergent Unveils Expanded Facility in Baltimore
Emergent Unveils Expanded Facility in Baltimore
The site will support the U.S. government’s national security and public health emergency needs
-
CPhI North America
Dow Offers New Technology to Solve Pharma Challenges
Dow Offers New Technology to Solve Pharma Challenges
Company’s silicone chemistries target cost control, product differentiation and solubility challenges
-
CPhI North America
SGS Expands Stability Capacity at Mississauga Lab
SGS Expands Stability Capacity at Mississauga Lab
Part of a broader global investment initiative in testing capabilities
-
CPhI North America
UPM Celebrates 100-Years of Mfg. at Tennessee Site
UPM Celebrates 100-Years of Mfg. at Tennessee Site
Bristol facility grows from a $25 hand-operated tablet machine to a 500,000 square-foot campus
-
CPhI North America
MilliporeSigma, SystImmune Partner for Bi-specific Antibody Development
MilliporeSigma, SystImmune Partner for Bi-specific Antibody Development
CHOZN expression system to be used to accelerate development timelines
-
CPhI North America
Cambrex Invests to Increase Pilot Scale API Capacity
Cambrex Invests to Increase Pilot Scale API Capacity
Increases High Point, NC, facility reactor capacity by 30%
-
CPhI North America
Catalent Biologics Collaborates with Therachon
Catalent Biologics Collaborates with Therachon
Will advance clinical development of innovative protein therapy for achondroplasia
-
CPhI North America
Aptar Pharma’s Electronic Lockout Device Approved by EMA
Aptar Pharma’s Electronic Lockout Device Approved by EMA
Reinforces a long-standing partnership between Aptar Pharma and Takeda
-
CPhI North America
PCI Begins Move-In Phase of European Clinical Site Expansion
PCI Begins Move-In Phase of European Clinical Site Expansion
Development doubles site capacity of Bridgend Center of Excellence
-
CPhI North America
Thermo Fisher Buys Patheon for $7.2B
Thermo Fisher Buys Patheon for $7.2B
Provides entry into the high-growth CDMO market
-
CPhI North America
Brammer Bio Achieves Milestone
Brammer Bio Achieves Milestone
Establishes commercial-ready gene therapy supply for the industry
-
CPhI North America
Halo Pharma Forms Pediatric Center of Excellence
Halo Pharma Forms Pediatric Center of Excellence
Will be dedicated to the development, reformulation, and manufacturing of drug products in pediatric dosage forms
-
CPhI North America
Catalent Manufactures Lexicon’s Xermelo Following Approval
Catalent Manufactures Lexicon’s Xermelo Following Approval
To provide commercial supply of first-in-class oral therapy from its Kansas City facility
-
CPhI North America
Patheon Completes NC Sterile Expansion
Patheon Completes NC Sterile Expansion
Invests $26 million in new sterile PDS suite
-
CPhI North America
Avantor to Acquire VWR for $6.4B
Avantor to Acquire VWR for $6.4B
Will create a vertically integrated, global player in manufacturing and supply chain solutions
-
CPhI North America
Alcami Invests $5M to Expand SC Ops
Alcami Invests $5M to Expand SC Ops
Will continue to expand its filling and freeze-drying capabilities
-
CPhI North America
Chartwell Adds Adents Serialization Software
Chartwell Adds Adents Serialization Software
Implements Adents Seriza for DSCSA compliance
-
CPhI North America
AMRI Wins Five-Year NIH Contract
AMRI Wins Five-Year NIH Contract
To provide drug substance development and manufacturing services
-
Interphex & DCAT WEEK ’17
Injectable Drug Delivery Trends
Injectable Drug Delivery Trends
Graham Reynolds of West discusses the latest drug delivery strategies and trends
-
Interphex & DCAT WEEK ’17
Alcami Introduces OnDemand Customer Portal Application
Alcami Introduces OnDemand Customer Portal Application
Aims to allow clients rapid access and visualization into their ongoing projects
